402 related articles for article (PubMed ID: 16741553)
21. Hepatorenal syndrome: new perspectives in pathophysiology and management.
Kes P
Acta Med Croatica; 2000; 54(4-5):165-73. PubMed ID: 11379481
[TBL] [Abstract][Full Text] [Related]
22. Hepatorenal syndrome: a review.
Testino G; Ferro C
Hepatogastroenterology; 2010; 57(102-103):1279-84. PubMed ID: 21410072
[TBL] [Abstract][Full Text] [Related]
23. TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?
Gülberg V; Gerbes AL
Z Gastroenterol; 2002 Sep; 40(9):823-6. PubMed ID: 12215953
[TBL] [Abstract][Full Text] [Related]
24. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
Møller S; Henriksen JH
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
[TBL] [Abstract][Full Text] [Related]
25. Review article: prognosis of hepatorenal syndrome--has it changed with current practice?
Angeli P
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():44-6; discussion 47-8. PubMed ID: 15335400
[TBL] [Abstract][Full Text] [Related]
26. Hepatorenal syndrome.
Cárdenas A; Arroyo V
Ann Hepatol; 2003; 2(1):23-9. PubMed ID: 15094702
[TBL] [Abstract][Full Text] [Related]
27. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
Moreau R; Lebrec D
Hepatology; 2006 Mar; 43(3):385-94. PubMed ID: 16496352
[TBL] [Abstract][Full Text] [Related]
28. [Hepatorenal syndrome in patients with liver cirrhosis].
Zaza S; Bonny O; Liaudet L
Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
[TBL] [Abstract][Full Text] [Related]
29. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
Arroyo V; Terra C; Ginès P
J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
[No Abstract] [Full Text] [Related]
30. Hepatorenal syndrome.
Guevara M; Ginès P
Dig Dis; 2005; 23(1):47-55. PubMed ID: 15920325
[TBL] [Abstract][Full Text] [Related]
31. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.
Møller S; Bendtsen F; Henriksen JH
Scand J Gastroenterol; 2005 May; 40(5):491-500. PubMed ID: 16036500
[TBL] [Abstract][Full Text] [Related]
32. [Therapy of hepatorenal syndrome].
Walter E
Praxis (Bern 1994); 1997 Jan; 86(4):102-3. PubMed ID: 9064719
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology, clinical features and management of hepatorenal syndrome.
Garzia P; Ferri GM; Ilardi M; Messina FR; Amoroso A
Eur Rev Med Pharmacol Sci; 1998; 2(5-6):181-4. PubMed ID: 10710816
[TBL] [Abstract][Full Text] [Related]
34. [Hepatorenal syndrome].
Lautrette A; Liotier J; Deteix P; Souweine B
Nephrol Ther; 2009 Apr; 5(2):150-6. PubMed ID: 18514053
[TBL] [Abstract][Full Text] [Related]
35. [Hepatorenal syndrome].
Radziszewski A; Sułowicz W
Przegl Lek; 2006; 63(7):573-8. PubMed ID: 17203812
[TBL] [Abstract][Full Text] [Related]
36. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
Gentilini P; Laffi G; La Villa G; Raggi VC
Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostics and therapy of hepatorenal syndrome. Recommendations of of the working group on portal hypertension of the Czech Hepatology Society and the J. E. Purkinje Czech Medical Society].
Brůha R; Skupiny C; Balihar K; Drastich P; Hůlek P; Lata J; Petrtýl J; Procházka V; Spicák J; Vanásek T; Volfová M; Zdenek P; ;
Vnitr Lek; 2006 Jun; 52(6):649-50. PubMed ID: 16871772
[TBL] [Abstract][Full Text] [Related]
38. [Hepatorenal syndrome].
Pŭrvanov P
Khirurgiia (Sofiia); 2002; 58(2):34-9. PubMed ID: 12515019
[TBL] [Abstract][Full Text] [Related]
39. [Hepatorenal syndrome: pathogenesis and treatment].
Ashkenazi E; Ilan Y; Shoval D
Harefuah; 2007 Jun; 146(6):475-9, 499. PubMed ID: 17760404
[TBL] [Abstract][Full Text] [Related]
40. [Hepatorenal syndrome].
Huschak G; Kaisers UX; Laudi S
Anaesthesist; 2013 Jul; 62(7):571-82. PubMed ID: 23846211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
